2001 Cannabinoids Data Treatment 
Veriheal
MAY 18, 2023
Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain.
Veriheal
AUGUST 7, 2022
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sensi Seeds
JANUARY 4, 2019
Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). He heads the Quebec Cannabis Registry and president of the Canadian Consortium for the Investigation of Cannabinoids, the body responsible for the conference.
CannaTech
SEPTEMBER 16, 2018
Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Cannabis medicine presents itself as an intimidating option despite patients requesting it as a form of treatment. Changing Cannabis Conversations Worldwide. Education and Resources to Drive Medical Cannabis.
Cannabis Law Report
AUGUST 19, 2019
Cannabinoids are the chemical substances found in cannabis. Over 100 different cannabinoids have been linked to the cannabis plant. To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. What substances are at issue? What is the relevant legislation?
The Cannigma
JANUARY 13, 2023
The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Daily cannabis consumption was an effective treatment for 85% of participants. headaches per month. headaches per month.
Cannabis Law Report
AUGUST 27, 2022
The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. The Court insisted that without being experts in the field, it could not examine the technical data regarding useful effects of Ganja etc. Appeals to Parliament.
Expert insights. Personalized for you.
98 
Let's personalize your content